U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Description
Curator's Comment: description was created based on several sources, including https://www.drugs.com/international/felypressin.html | https://clinicaltrials.gov/ct2/show/NCT01073371 | https://www.mims.com/India/drug/info/prilocaine%20%2B%20felypressin/?type=full&mtype=generic#Indications | https://www.ncbi.nlm.nih.gov/pubmed/18655903 | https://www.ncbi.nlm.nih.gov/pubmed/3040881

Felypressin is a non-catecholamine vasoconstrictor that is chemically related to vasopressin, the posterior pituitary hormone. Felypressin is added to some local anesthetics such as prilocaine in a concentration of 0.03 IU/ml. Its antidiuretic effects are less than those of vasopressin. Felypressin is used as a vasoconstrictor in local anesthetic injections for dental use and is an ingredient of preparations that have been used for the treatment of pain and inflammation of the mouth.

Originator

Sources: Tydschr. Diergeneesk, Volume 85, Pages 18-22, Journal,1960

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Felypressin

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Mechanism of epinephrine enhancement of lidocaine-induced skeletal muscle necrosis.
1982 May
Severe hypertension during anaesthesia for dacryocystorhinostomy.
1985 Aug
Patents

Sample Use Guides

Adult: As combination containing prilocaine hydrochloride 30 mg and felypressin 0.03 IU/ml: Usual dose: 1-5 ml, adjust according to response. Max: 10 ml. Child: As combination containing prilocaine hydrochloride 30 mg and felypressin 0.03 IU/ml: <10 yr: 1-2 ml; 10-18 yr: 1-5 ml, max 10ml. Adjust dose according to response.
Route of Administration: Intramuscular
In Vitro Use Guide
Adenohypophyses, removed from decapitated rats, were divided into four segments of approximately equal size and incubated together for 150 min at 37 °C in 2-0 ml medium, ionically similar to cerebrospinal fluid containing ascorbic acid (1 mmol/1; pH 7-4), through which 95% O2 / 5% CO2 was passed continually. The medium was replaced after 120 and 135 min. The pituitary segments were then separated and incubated for a further 15 min, either in medium (1-0 ml) con¬ taining vasopressin-receptor agonist Felypressin and/or CRF-41 or in a corresponding volume of medium alone (controls). The medium was stored at -30 °C and its ACTH concentration determined subsequently
Name Type Language
FELYPRESSIN
EP   INN   MART.   MI   USAN   WHO-DD  
INN   USAN  
Official Name English
FELYPRESSIN [EP IMPURITY]
Common Name English
CYS-PHE-PHE-GLN-ASN-CYS-PRO-LYS-GLY-NH2 (1-6 DISULFIDE)
Common Name English
felypressin [INN]
Common Name English
Felypressin [WHO-DD]
Common Name English
VASOPRESSIN, 2-L-PHENYLALANINE-8-L-LYSINE-
Common Name English
PLV-2
Code English
2-(L-PHENYLALANINE)-8-L-LYSINEVASOPRESSIN
Common Name English
L-CYSTEINYL-L-PHENYLALANYL-L-PHENYLALANYL-L-GLUTAMINYL-L-ASPARAGINYL-L-CYSTEINYL-L-PROLYL-L-LYSYLGLYCINAMIDE CYCLIC (1->6)DISULPHIDE
Common Name English
FELYPRESSIN [MART.]
Common Name English
FELYPRESSIN [EP MONOGRAPH]
Common Name English
CYS-PHE-PHE-GLN-ASN-CYS-PRO-LYS-GLY-NH2 (1-6 DISULPHIDE)
Common Name English
L-CYSTEINYL-L-PHENYLALANYL-L-PHENYLALANYL-L-GLUTAMINYL-L-ASPARAGINYL-L-CYSTEINYL-L-PROLYL-L-LYSYLGLYCINAMIDE CYCLIC (1->6)DISULFIDE
Common Name English
FELYPRESSIN [MI]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C80212
Created by admin on Fri Dec 15 16:22:21 GMT 2023 , Edited by admin on Fri Dec 15 16:22:21 GMT 2023
Code System Code Type Description
EVMPD
SUB07529MIG
Created by admin on Fri Dec 15 16:22:21 GMT 2023 , Edited by admin on Fri Dec 15 16:22:21 GMT 2023
PRIMARY
RXCUI
4319
Created by admin on Fri Dec 15 16:22:21 GMT 2023 , Edited by admin on Fri Dec 15 16:22:21 GMT 2023
PRIMARY RxNorm
DRUG BANK
DB00093
Created by admin on Fri Dec 15 16:22:21 GMT 2023 , Edited by admin on Fri Dec 15 16:22:21 GMT 2023
PRIMARY
MESH
D005259
Created by admin on Fri Dec 15 16:22:21 GMT 2023 , Edited by admin on Fri Dec 15 16:22:21 GMT 2023
PRIMARY
INN
1359
Created by admin on Fri Dec 15 16:22:21 GMT 2023 , Edited by admin on Fri Dec 15 16:22:21 GMT 2023
PRIMARY
EPA CompTox
DTXSID6048599
Created by admin on Fri Dec 15 16:22:21 GMT 2023 , Edited by admin on Fri Dec 15 16:22:21 GMT 2023
PRIMARY
MERCK INDEX
m5258
Created by admin on Fri Dec 15 16:22:21 GMT 2023 , Edited by admin on Fri Dec 15 16:22:21 GMT 2023
PRIMARY Merck Index
SMS_ID
100000091379
Created by admin on Fri Dec 15 16:22:21 GMT 2023 , Edited by admin on Fri Dec 15 16:22:21 GMT 2023
PRIMARY
NCI_THESAURUS
C81496
Created by admin on Fri Dec 15 16:22:21 GMT 2023 , Edited by admin on Fri Dec 15 16:22:21 GMT 2023
PRIMARY
DRUG CENTRAL
4910
Created by admin on Fri Dec 15 16:22:21 GMT 2023 , Edited by admin on Fri Dec 15 16:22:21 GMT 2023
PRIMARY
FDA UNII
17N2918V6G
Created by admin on Fri Dec 15 16:22:21 GMT 2023 , Edited by admin on Fri Dec 15 16:22:21 GMT 2023
PRIMARY
ECHA (EC/EINECS)
200-282-7
Created by admin on Fri Dec 15 16:22:21 GMT 2023 , Edited by admin on Fri Dec 15 16:22:21 GMT 2023
PRIMARY
CAS
56-59-7
Created by admin on Fri Dec 15 16:22:21 GMT 2023 , Edited by admin on Fri Dec 15 16:22:21 GMT 2023
PRIMARY
PUBCHEM
14257662
Created by admin on Fri Dec 15 16:22:21 GMT 2023 , Edited by admin on Fri Dec 15 16:22:21 GMT 2023
PRIMARY
CHEBI
60564
Created by admin on Fri Dec 15 16:22:21 GMT 2023 , Edited by admin on Fri Dec 15 16:22:21 GMT 2023
PRIMARY
ChEMBL
CHEMBL1908309
Created by admin on Fri Dec 15 16:22:21 GMT 2023 , Edited by admin on Fri Dec 15 16:22:21 GMT 2023
PRIMARY
WIKIPEDIA
FELYPRESSIN
Created by admin on Fri Dec 15 16:22:21 GMT 2023 , Edited by admin on Fri Dec 15 16:22:21 GMT 2023
PRIMARY